141 related articles for article (PubMed ID: 147851)
1. Dietary enhancement of CNS neurotransmitters.
Wurtman RJ; Growdon JH
Hosp Pract; 1978 Mar; 13(3):71-7. PubMed ID: 147851
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Davis KL; Berger PA
Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic influences in tardive dyskinesia.
Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
[TBL] [Abstract][Full Text] [Related]
4. Oral choline administration to patients with tardive dyskinesia.
Growdon JH; Hirsch MJ; Wurtman RJ; Wiener W
N Engl J Med; 1977 Sep; 297(10):524-7. PubMed ID: 887103
[TBL] [Abstract][Full Text] [Related]
5. Treatment of brain disease with dietary precursors of neurotransmitters.
Growdon JH; Cohen EL; Wurtman RJ
Ann Intern Med; 1977 Mar; 86(3):337-9. PubMed ID: 14577
[TBL] [Abstract][Full Text] [Related]
6. Effects on the diet on brain neurotransmitters.
Fernstrom JD
Metabolism; 1977 Feb; 26(2):207-23. PubMed ID: 13261
[TBL] [Abstract][Full Text] [Related]
7. Choline in tardive dyskinesia and Huntington's disease.
Davis KL; Hollister LE; Barchas JD; Berger PA
Life Sci; 1976 Nov; 19(10):1507-15. PubMed ID: 136581
[No Abstract] [Full Text] [Related]
8. Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report.
Davis KL; Berger PA; Hollister LE; Simonton SC
Psychopharmacol Bull; 1977 Jul; 13(3):37-8. PubMed ID: 142261
[No Abstract] [Full Text] [Related]
9. Effects of choline on tardive dyskinesia and other movement disorders.
Growdon JH
Psychopharmacol Bull; 1978 Oct; 14(4):55-6. PubMed ID: 151871
[No Abstract] [Full Text] [Related]
10. Cholinergic treatments for tardive dyskinesia.
Alphs LD; Davis JM
Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629
[No Abstract] [Full Text] [Related]
11. Studies on choline chloride in neuropsychiatric disease: human and animal data.
Davis KL; Hollister LE; Berger PA; Vento AL
Psychopharmacol Bull; 1978 Oct; 14(4):56-8. PubMed ID: 151872
[No Abstract] [Full Text] [Related]
12. The use of cholinergic precursors in neuropsychiatric diseases.
Rosenberg GS; Davis KL
Am J Clin Nutr; 1982 Oct; 36(4):709-20. PubMed ID: 6214943
[TBL] [Abstract][Full Text] [Related]
13. Use of choline and lecithin in the treatment of tardive dyskinesia.
Zeisel SH; Gelenberg AJ; Growdon JH; Wurtman RJ
Adv Biochem Psychopharmacol; 1980; 24():463-70. PubMed ID: 6996444
[No Abstract] [Full Text] [Related]
14. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study.
Gelenberg AJ; Doller-Wojcik JC; Growdon JH
Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755
[TBL] [Abstract][Full Text] [Related]
15. Variable clinical response to choline in tardive dyskinesia.
Nasrallah HA; Dunner FJ; Smith RE; McCalley-Whitters M; Sherman AD
Psychol Med; 1984 Aug; 14(3):697-700. PubMed ID: 6387757
[TBL] [Abstract][Full Text] [Related]
16. Oral choline in tardive dyskinesia.
Ray R; Ramakrishnan N; Rao BS
Indian J Med Res; 1982 Oct; 76():628-31. PubMed ID: 7152571
[No Abstract] [Full Text] [Related]
17. Lecithin consumption raises serum-free-choline levels.
Wurtman RJ; Hirsch MJ; Growdon JH
Lancet; 1977 Jul; 2(8028):68-9. PubMed ID: 69151
[TBL] [Abstract][Full Text] [Related]
18. Deanol acetamidobenzoate treatment in choreiform movement disorders.
Tarsy D; Bralower M
Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
[TBL] [Abstract][Full Text] [Related]
19. The biochemical background to tardive dyskinesia.
Ansell GB
Neuropharmacology; 1981 Apr; 20(4):311-7. PubMed ID: 7027074
[No Abstract] [Full Text] [Related]
20. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
Eckernäs SA
Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
[No Abstract] [Full Text] [Related]
[Next] [New Search]